SynBioBeta Speaker
Beatrix Ellis
CEO
GitLife Biotech
YEAR
25
May 2025, SynBioBeta
Keynote Speaker
SynBioBeta 2025 - Keynote
Scaling SynBio: Investment Strategies from Lab to Market
Transitioning synthetic biology innovations from the lab to commercial scale requires strategic investment, robust infrastructure, and cross-sector collaboration. This session explores the financial and operational challenges of scaling the bioeconomy in the UK and Europe, highlighting key funding mechanisms, investor perspectives, and case studies of successful scale-ups. Join this session to understand the investment landscape, technology readiness, and market adoption and hear insights for startups and stakeholders looking to bridge the gap between research and commercialization.
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Other Speakers
Other Speakers
2026
Event Updates